Events5th International Electronic Conference on Medicinal Chemistry
Published
This submission belongs to the session A. ECMC-5 of the event 5th International Electronic Conference on Medicinal Chemistry
Published date
30 Oct, 2019
Citation
Tomasz M. Karpiński, Artur Adamczak, Marcin Ożarowski, Antibacterial activity of apigenin, luteolin, and their C-glucosides, in Proceedings of 5th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2019, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2019-06321
Share
Email
Facebook
Twitter
LinkedIn

Antibacterial activity of apigenin, luteolin, and their C-glucosides

image
image
image
1. Department of Medical Microbiology, Poznań University of Medical Sciences, Wieniawskiego 3, 61-712 Poznań, Poland, Poland
2. Department of Botany, Breeding and Agricultural Technology of Medicinal Plants, Institute of Natural Fibres and Medicinal Plants, Kolejowa 2, 62-064 Plewiska, Poland
3. Department of Biotechnology, Institute of Natural Fibres and Medicinal Plants, Wojska Polskiego 71b, 60-630 Poznań, Poland
Abstract

Apigenin (4′,5,7-trihydroxyflavone) and luteolin (3′,4′,5,7-tetrahydroxyflavone) are among the most widely distributed flavone aglycones in flowering plants. These metabolites often occur in the form of O- and C-glycosides. In this group, four C-glucosides pay special attention: vitexin (apigenin 8-C-glucoside) and isovitexin (apigenin 6-C-glucoside) as well as orientin (luteolin 8-C-glucoside) and isoorientin (luteolin 6-C-glucoside). The above-mentioned compounds show various biological activities, including antioxidant, anti-inflammatory, immunomodulatory, anticancer as well as neuro-, cardio-, and hepatoprotective effects. The aim of the present work was to determine the antibacterial activity of these flavones.

In the in vitro tests, there were investigated clinical strains of two Gram-positive (Staphylococcus aureus, Enterococcus faecalis) and Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa). The antimicrobial activity of chosen substances was determined by the micro-dilution method according to recommendations of the Clinical and Laboratory Standards Institute (CLSI). Curcumin was used as a positive control.

Our results exhibited a relatively low sensitivity of the tested strains to the plant metabolites. In the case of curcumin – natural compound with known strong antibacterial effect, the minimal inhibitory concentration (MIC) for all species of bacteria was 500 μg/mL. The same level of biological activity was observed for apigenin, luteolin, and their glucosides against E. coli and P. aeruginosa. Among Gram-positive bacteria, the obtained results showed significant variability. Strains of S. aureus demonstrated a weak sensitivity to apigenin (MIC = 500-1000 μg/mL), and were resistant to its derivatives: vitexin and isovitexin (>1000 μg/mL). Additionally, these compounds poorly inhibited the growth of E. faecalis (1000 μg/mL). In turn, luteolin and its C-glucosides (orientin, isoorientin) reached the same values of the MICs: moderate against S. aureus (500 μg/mL) and weak for E. faecalis (1000 μg/mL).

Our research points to the problem of varied sensitivity and even resistance of some clinical strains of common pathogens to the widespread natural plant compounds, such as flavonoids and other phenolics (e.g., curcumin). It is interesting that apigenin, luteolin, and their C-glucosides were generally more potent against Gram-negative bacteria than Gram-positive ones. A pair of analysed flavone aglycones has a very similar chemical structure, and they did not differ significantly in the antibacterial activity. Similarly, the presence and location of the sugar group in the flavone glucosides usually did not affect the values of the MICs.

Keywords
Apigenin
Luteolin
Vitexin
Isovitexin
Orientin
Isoorientin
Antimicrobial
Antibacterial
Minimal inhibitory concentration (MIC)
Manuscript
Poster
Flavonoids_ Presentation_MO.pdf
Synthesis, biological evaluation and membranotropic properties of quinoline-antimicrobial peptide conjugates as antibacterial drugs
In vitro antimicrobial effect of curcumin